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Abstract: Ninety-two patients with moderate or severe chronic obstructive pulmonary disease 
(COPD) were assessed for walking tolerance, lung function, perceived health status (HS), 
perceived quality of life (QoL) and anxiety before and after a four weeks inpatient pulmonary 
rehabilitation (PR) program. There were signifi cant improvements on all outcomes except anxi-
ety, although the effect sizes were small or moderate. The largest improvement was observed 
on the walking test, but patients also improved on perceived health status (HS) and perceived 
quality of life (QoL). Relations between outcome indicators were analyzed cross-sectionally 
and longitudinally. Cross-sectional correlations were in line with earlier studies. However, 
improvements on the walking test were generally unrelated to changes in lung function, HS and 
QoL. Different patients improve on different outcome measures following PR, and this could 
have implications for the planning and designs of PR programs.
Keywords: COPD, pulmonary rehabilitation (PR), health status (HS), quality of life (QoL)
Introduction
Chronic obstructive pulmonary disease (COPD) can have a substantial effect on the 
physical, emotional and social aspects of patients’ lives (Guthrie et al 2001). Activi-
ties of daily living are often considerably impeded (McSweeny et al 1982) and many 
COPD patients suffer from emotional problems such as anxiety and depression (Kunik 
et al 2005). Perceived health status (HS) and quality of life (QoL) tend to be low in 
COPD (Prigatano et al 1984; Yohannes et al 1998).
Questionnaires, such as HS instruments, QoL instruments or anxiety/depression 
inventories, and physical indicators – eg, spirometric values or walking tests – have 
several uses. First, they can show how patients’ lives are affected by COPD; second 
they are useful to evaluate effects of pulmonary rehabilitation (PR) programs. Such 
effects have been well documented (Ambrosino 2002; Lacasse et al 2002; Salman et al 
2003), but the magnitude of improvement has varied considerably, both for physical 
tests and self-reported outcome variables.
In this study we assessed a sample of COPD patients on a set of outcome variables 
before and after a PR program. The fi rst aim of our study was to assess whether physi-
cally related variables would improve more than emotionally related variables, since 
the rehabilitation program was focused primarily on physical exercise. However, since 
COPD is a chronic disease, we did not expect any major changes in lung function for 
the sample.
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Previous studies have shown that cross-sectional 
correlations between objective versus subjective indicators 
tend to be low, but walking distance has been moderately and 
signifi cantly correlated to self-reported health status (Jones 
and Kaplan 2003; Haave et al 2005). Few studies, however, 
have investigated whether longitudinal change in one out-
come variable correlates with change in another outcome 
variable. The second aim of our study was therefore to assess 
the relations between changes in different outcome variables. 
Our main expectation was that changes in exercise capacity 
(walking distance) would be at least moderately related to 
changes in perceived health status and quality of life – par-
ticularly to the physically related subscores. That is, we 
expected that if patients responded well to PR by improving 
their exercise capacity, this would be refl ected in consistent 
improvement across several other outcome variables.
Method
Patients and procedures
Data were collected from a sample of COPD patients who had 
been referred to a four-week inpatient PR program at a clinic 
in Norway. Patients were included if they had been given a 
diagnosis of COPD from their regular physician before enter-
ing the clinic, and were excluded if they were known to have 
any known serious somatic or psychological problems in addi-
tion to their COPD. Patients older than 70-years and patients 
using long term oxygen therapy (LTOT) were also excluded. 
Patients completed questionnaires at home: two weeks before 
and two weeks after the rehabilitation program. Lung function 
measurements and walking tests were performed at the clinic, 
during the fi rst and the last week of the rehabilitation program. 
For purposes of analysis, we included only patients who had 
completed all questionnaires and performed all walking tests 
and lung function tests. A total of 95 patients fulfi lled these 
criteria. Subsequently, three patients were excluded because 
their diagnosis was changed from COPD to asthma during 
their stay at the clinic, thus leaving a sample of 92 patients.
Patients were informed that participation in the research 
project was voluntary and that information would be treated 
confi dentially. Those who wanted to participate gave their 
written consent. The regional ethical committee had approved 
the study.
Rehabilitation program
Patients participated in a four weeks multidisciplinary PR 
program, in which the central elements were physical exer-
cise, educational lectures, lifestyle change support and social 
sharing with other COPD patients. The program consisted of 
three to four 45 min educational or exercise group sessions 
all weekdays. Patients were seen at least weekly by their 
attending physician, and issues such as medication or nutrition 
were followed up regularly by nurses. All patients were given 
individual appointments with a physiotherapist. Individual 
appointments with a social worker, occupational therapist, 
nutritional adviser and psychologist were given as needed.
Measures
Quality of life
Quality of life was measured by the Perceived Quality of 
Life Scale (PQoL). The PQoL is a generic, not health-related, 
instrument (Patrick 2004) including 19 items in which the 
participants rate their satisfaction with different aspects of 
life on an 11-point end-anchored scale from 0 (“extremely 
dissatisfi ed”) to 10 (“extremely satisfi ed”), plus one extra 
item that measure happiness. The PQoL total score (PQoL 
tot) was calculated as the mean of the fi rst nineteen differ-
ent items. Two subscores were calculated: A physical score 
(PQoL phys) and a social score (PQoL social). All PQoL 
scores had a possible range from 0,0 to 10,0. Higher PQoL 
scores mean better perceived quality of life.
Health status
Perceived and disease-specifi c health status was measured by 
the short version of the Breathing Problems Questionnaire 
(BPQ), in which the patients describe how their breathing 
problems infl uence different aspects and functions of daily 
life. The BPQ short version (Hyland et al 1998) has 10 items, 
each with a scoring range 0–3, which can be added to a BPQ 
total score (BPQ total) that ranges from 0 to 30. In addition 
to the total score, a BPQ physical subscore (BPQ phys) and 
a BPQ emotional subscore (BPQ emo) was calculated, both 
with a score range from 0 to 12. Higher BPQ scores mean 
worse perceived health status.
Anxiety
Anxiety was measured by the trait part of Spielberger’s state/
trait anxiety inventory (STAI) (Håseth et al 1993). The scale 
consists of 20 questions, each with a scoring range 1–4, some 
of them in reversed order, which can be added to calculate 
a trait anxiety total score that ranges from 20 to 80. Higher 
STAI scores mean higher anxiety levels.
Lung function
Lung function was measured as forced expiratory volume 
in 1 s (FEV
1
) recorded from the better of two fl ow-volume 
curves (Jaeger, Masterlab) and presented as percent of 
expected values, adjusted for age, gender and height (FEV
1
%) 
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(Quanjer et al 1993). Higher FEV
1
% scores mean better lung 
function.
Exercise capacity
Exercise capacity was measured by 6-minute walking tests 
(6MWD) according to ATS guidelines (Nici 2002). All tests 
were conducted indoors, along fl at, straight corridors with 
30 meters marked walking courses. In the instruction, patients 
were instructed to walk as far as possible for 6 minutes, but 
permitted to slow down, to stop, and to rest as necessary. 
Standard phrases of encouragement such as “you are doing 
well” and “keep up the good work” were given once every 
minute. The results on the 6MWD were reported in meters; 
higher 6MWD scores mean better test results.
Statistics
T-tests for paired samples were used to analyze changes in 
scores over time. Cohen’s d was used as an estimate of effect 
size, and was calculated by dividing the mean change score for 
a variable with the pooled standard deviation of raw scores on 
the same variable, from before to after rehabilitation. Values 
of d were interpreted as follows: d  0.2 = small effects, 
0.2  d  0.5 = medium effects, d  0.5 = large effects.
Pearson parametric correlation coeffi cients were calcu-
lated to analyze cross-sectional correlations between the main 
variables in the study. However, since change scores tend 
to have low reliability, correlations between such variables 
were not calculated. For the purpose of analyzing associa-
tions between variable changes, we did as follows. Using the 
criterion of change in walking tests (Δ6MWD), patients were 
allocated into one of three groups: Group 1 = worsening or 
no improvement (Δ6MWD  0), N = 29; Group 2 = small 
or moderate improvement (0  Δ6MWD  40), N = 32; 
Group 3 = large improvement (Δ6MWD  40), N = 31. 
Then, these three groups of patients were tested for changes 
over time on other variables by repeated measures ANOVAs. 
Age and gender were used as covariates in these analyses. 
In addition to this, we counted how many of the 92 patients 
had improved their scores from before to after rehabilitation; 
on separate variables and on combination of variables. SPSS 
version 15.0.1 was used for all statistical analyses.
Results
The sample consisted of 50 women and 42 men. Mean age 
was 59.2 years (S.D. = 5.7, range = 42–69), showing that 
ours was a relatively young sample of COPD patients. At 
the start of the PR program, mean FEV
1
% for the sample 
was 50.8 (S.D. = 18.9, range 19–97), showing that our 
sample of patients could be characterized as moderate to 
severe COPD.
Table 1 shows the cross-sectional correlation coeffi cients 
between outcome variables assessed before the rehabilitation 
program. Walking distance was moderately and signifi cantly 
correlated to lung function and HS, less to QoL and near zero 
to anxiety. Lung function was also signifi cantly correlated 
to HS, but not to QoL or anxiety. HS, QoL and anxiety were 
all signifi cantly correlated to each other, and the strongest 
correlations were observed between QoL and anxiety.
Scores before and after rehabilitation, t-values, sig-
nifi cance levels and effect sizes are shown in Table 2. All 
variables changed in a positive direction, and all, except 
for trait anxiety, the emotional subscale of the BPQ and 
the social subscale of the PQoL, were signifi cant. Effect 
sizes were small or moderate. Walking distance and the 
physically related HS and QoL subscores showed the largest 
improvements.
53 patients improved on the BPQ total, 58 patients 
improved on the PQoL total, but only 37 patients improved 
on both these variables. 27 patients improved on the com-
bination of 6MWD, BPQ total and PQoL total, and as few 
as 11 patients improved on all fi ve main variables (6MWD, 
BPQ total, PQoL total, FEV
1
% and STAI).
Table 3 shows the mean score on outcome variables after 
classifying patients in terms of their degree of improvement 
of the 6MWD. There were no signifi cant effects, showing 
that change in 6MWD was unrelated to change in any other 
outcome variable.
Discussion
In this study of PR, we found that the longitudinal association 
between exercise capacity and other outcome variables was 
poor. While the 6MWD was signifi cantly correlated to other 
variables cross-sectionally, changes in walking distance were 
largely unrelated to changes in the other outcome variables. 
The degree of increased walking distance was not accompanied 
by comparable degrees of improvements on HS, QoL or lung 
function. Contrary to our expectation we found no relation 
Table 1 Correlations coeffi cients between main variables before 
the rehabilitation program, N = 92
 FEV1% BPQ total PQoL total STAI
6MWD 0.57** –0.55** 0.26 –0.02
FEV1% – –0.42** 0.16 –0.09
BPQ total  – –0.58** 0.48**
PQoL total   – –0.69**
Note: *p  0.01, **p  0.001.
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between changes in walking distance and changes in the physi-
cally related subscores of HS and QoL. These results suggest 
that COPD patients do not respond uniformly to a PR program, 
or to different parts of a PR program. For example; patients who 
have not managed to increase their exercise capacity during 
the 4-weeks of rehabilitation, may still have made signifi cant 
progress pertaining to how they think and feel about their health 
status, daily functioning or satisfaction with life. It seems rea-
sonable to consider both subjective and objective improvements 
as important outcomes, and it underscores the importance of 
using a battery of instruments and tests for evaluation purposes 
(Engstrom et al 2001). Results in line with ours were reported 
in a study correlating 6MWD change scores with change scores 
for other variables (de Torres et al 2002).
The cross-sectional patterns of associations between outcome 
variable in this study were consistent with previous research, as 
both walking distance and HS were signifi cantly associated with 
lung function (Antonelli-Inc R et al 2003; Carter et al 2003), 
while associations between lung function and more general 
QoL were nonsignifi cant or low (Monso et al 1998). Walking 
distance was associated with HS but more weakly associated 
with generic QoL (Singh et al 2001; Katsura e al 2003). Finally, 
HS, QoL and anxiety were signifi cantly associated to each other 
at both times of measurement (Andenaes et al 2004).
The greatest improvements after the PR program were 
those of physical performance and perceived physical func-
tioning; walking distance and the physical subscores of BPQ 
and PQoL changed most, and this may be attributable to the 
physical orientation of this PR program. However, since 
the emotional and social subscores were lower at baseline, 
the potential for improvement was probably smaller on these 
scales. The increase in walking distance has been reported 
in many previous studies (Strijbos et al 1996; Engstrom et al 
1999; Griffi ths et al 2000; Guell et al 2000). A signifi cant 
improvement in lung function was unexpected, however, 
since other rehabilitation studies do not tend to fi nd such 
effects (Fuchs-Climent et al 2001; Trappenburg et al 2005). 
One study discovered FEV
1
% improvements at discharge, 
and attributed the effect to better compliance (Buchi et al 
1997). Similar mechanisms may have been responsible for 
the improvements in our sample. We found no reduction 
Table 3 Changes in walking distance related to changes in the other main variables
Variables  Group 1: Group 2: Group 3: Group × time
  Worsening or no Small or moderate Large improvement
  improvement improvement on the 6MWD
  on the 6MWD on the 6MWD
  N = 29 N = 32 N = 31 p Value
BPQ tot  t1 11.8 (5.3) 10.2 (6.2) 10.5 (4.6) p = 0.650
 t2 10.5 (5.6) 9.5 (6.6) 10.0 (4.9)
BPQ phys t1 4.7 (2.4) 4.1 (2.5) 4.2 (2.1) p = 0.900
 t2 4.1 (2.4) 3.7 (2.7) 3.9 (2.1)
PQoL tot  t1 4.7 (1.6) 5.2 (1.7) 5.2 (1.7) p = 0.586
 t2 5.2 (1.7) 5.4 (1.9) 5.5 (1.6)
PQoL phys t1 4.1 (1.9) 4.9 (1.9) 4.9 (1.9) p = 0.507
 t2 4.8 (1.7) 5.2 (2.2) 5.4 (1.6)
STAI t1 44.4 (12.2) 42.2 ( 9.5) 41.6 (10.8) p = 0.366
 t2 44.0 (12.8) 43.1 (12.3) 40.2 ( 9.6)
FEV1% t1 51.1 (21.2) 48.7 (16.9) 52.7 (19.0) p = 0.925
 t2 53.4 (22.2) 50.8 (17.7) 55.6 (18.7)
Group1: (Δ6MWD  0 meters), Group 2 : (0  Δ6MWD  40 meters), Group 3 : (Δ6MWD  40 meters). 
Table 2 Scores before and after the rehabilitation program, N = 92
Variables Scores before Scores after p-values Effect
 rehabilitation: rehabilitation:  size
 Means (SD) Means (SD)  Cohen’s d
FEV1% 50.78 (18.92) 53.23 (19.41) p = 0.001 0.13
6MWD 500.54 (114.61) 528.42 (123.85) p  0.001 0.23
BPQ total 10.83 (5.39) 9.99 (5.71) p = 0.006 0.15
BPQ phys 4.30 (2.35) 3.88(2.40) p = 0.001 0.18
BPQ emo 3.60 (2.49) 3.39(2.57) p = 0.236 0.08
PQoL total 5.06 (1.67) 5.36 (1.70) p = 0.014 0.18
PQoL phys 4.62 (1.94) 5.15 (1.88) p = 0.001 0.28
PQoL social 5.10 (1.76) 5.31 (1.79) p = 0.072 0.12
STAI 42.73 (10.77) 42.38 (11.61) p = 0.610 0.03
Notes: FEV1%: forced expiratory volume in one second presented as percent of 
expected values, adjusted for age, gender and height.
Abbreviations: 6MWD, 6 minutes walking test presented in meters; BPQ total, 
total score on the Breathing Problems Questionnaire; BPQ phys, physical subscore 
on the Breathing Problems Questionnaire; BPQ emo, emotional subscore on 
the Breathing Problems Questionnaire; PQoL total, total score on the Perceived 
Quality of Life Scale; PQoL phys, physical subscore on the Perceived Quality of Life 
Scale; PQoL social, social subscore on the Perceived Quality of Life Scale; STAI, trait 
anxiety score on the Spielberger state/trait anxiety scale.
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in anxiety levels, but two studies using cognitive therapy 
(de Godoy and de Godoy 2003) and cognitive behavioral 
therapy (Kunik et al 2001) showed anxiety reduction among 
COPD patients. Such elements, however, were not systemati-
cally included in our PR program. The content and durations 
of PR programs are controversial. Some believe that while a 
PR program of 4–10 weeks may improve physical function, 
modifi cation of coping styles and emotional states may take 
months (Wempe and Wijkstra 2004). Our results could be 
relevant to this discussion, since they demonstrated that a 
relatively short PR program with a main focus on physical 
exercise and educational sessions could not produce signifi -
cant emotional improvements for COPD patients.
There were limitations to our study. Questionnaires were 
completed two weeks before and two weeks after the PR 
program while walking tests and lung function tests were 
performed at the clinic. Furthermore, measurements based on 
self-report are qualitatively different from tests of physical per-
formance, which may have explained some of the divergences 
between indicators. Finally, as regards the effects of PR; this 
study did not include a control group, hence effects of the 
program must be considered with caution. Nevertheless, these 
results added to the total picture of effects of PR on COPD.
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